Viewing StudyNCT01103791



Ignite Creation Date: 2024-05-05 @ 10:26 PM
Last Modification Date: 2024-10-26 @ 10:18 AM
Study NCT ID: NCT01103791
Status: COMPLETED
Last Update Posted: 2017-05-05
First Post: 2010-04-05

Brief Title: A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP Polymeric Nanoparticle Formulation of Docetaxel in Subjects With Advanced Solid Malignancies
Sponsor:
Organization: Samyang Biopharmaceuticals Corporation